Cargando…
Myocardial protective and anti-inflammatory effects of dexmedetomidine in patients undergoing cardiovascular surgery with cardiopulmonary bypass: a systematic review and meta-analysis
Cardiopulmonary bypass (CPB) technology provides potential for cardiac surgery, but it is followed by myocardial injury and inflammation related to ischemia–reperfusion. This meta-analysis aimed to systematically evaluate the cardioprotective effect of dexmedetomidine on cardiac surgery under CPB an...
Autores principales: | Chen, Milian, Li, Xia, Mu, Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330189/ https://www.ncbi.nlm.nih.gov/pubmed/34342722 http://dx.doi.org/10.1007/s00540-021-02982-0 |
Ejemplares similares
-
Dexmedetomidine decreases the inflammatory response to myocardial surgery
under mini-cardiopulmonary bypass
por: Bulow, N.M.H., et al.
Publicado: (2016) -
The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass
por: Pan, Sining, et al.
Publicado: (2020) -
Efficacy of dexmedetomidine on myocardial ischemia/reperfusion injury in patients undergoing cardiac surgery with cardiopulmonary bypass: A protocol for systematic review and meta-analysis
por: Liang, Gencheng, et al.
Publicado: (2023) -
Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
por: Ji, Fuhai, et al.
Publicado: (2013) -
Effect of ischemic postconditioning on myocardial protection in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass
por: Safaei, Nasser, et al.
Publicado: (2016)